Skip to content

Tenofovir kidney toxicity most likely with high blood pressure medications and PIs

Prevention – there will be no magic bullet, we need ‘combination prevention’

AIDS in 2031: where will we be?

Major prevention success for sex workers and men who have sex with men in India

Infants starting HIV treatment less likely to completely suppress viral load

Slowing CD4 cell decline with IL-2 allows HIV treatment to be deferred by 92 weeks

Efavirenz superior to lopinavir/ritonavir in very advanced HIV, Mexican trial shows

Raltegravir versus efavirenz in treatment-naïves at 96 weeks: continued efficacy and fewer adverse effects

Treatment outcomes in Latin America, China and Botswana: successes and shortfalls